102 related articles for article (PubMed ID: 19572347)
1. [Microplasmin instead of a scalpel].
Heidingsfeld A; Koob V; Kräuter N; Kupka J; Rastetter A; Zündorf I; Dingermann T
Pharm Unserer Zeit; 2009; 38(4):299-300. PubMed ID: 19572347
[No Abstract] [Full Text] [Related]
2. A novel human microplasmin fold: new perspective to thrombosis treatment.
Joison AN; Gallo FS
Blood Coagul Fibrinolysis; 2011 Apr; 22(3):236-9. PubMed ID: 21245749
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human microplasmin: production and potential therapeutic properties.
Nagai N; Demarsin E; Van Hoef B; Wouters S; Cingolani D; Laroche Y; Collen D
J Thromb Haemost; 2003 Feb; 1(2):307-13. PubMed ID: 12871505
[TBL] [Abstract][Full Text] [Related]
4. Experimental evaluation of microplasmin - an alternative to vital dyes.
Gandorfer A
Dev Ophthalmol; 2008; 42():153-159. PubMed ID: 18535388
[TBL] [Abstract][Full Text] [Related]
5. Microplasmin (ocriplasmin) in pediatric vitreoretinal surgery: update and review.
Wong SC; Capone A
Retina; 2013 Feb; 33(2):339-48. PubMed ID: 23001068
[TBL] [Abstract][Full Text] [Related]
6. Effects of microplasmin on recovery in a rat embolic stroke model.
Rasmussen RS; Overgaard K; Pakola S; Boysen G
Neurol Res; 2008 Feb; 30(1):75-81. PubMed ID: 17588313
[TBL] [Abstract][Full Text] [Related]
7. Newer fibrinolytic agents.
Cliffton EE
Vasc Dis; 1966 Apr; 3(2):75-83. PubMed ID: 4222874
[No Abstract] [Full Text] [Related]
8. Effect of microplasmin on the clearance of vitreous haemorrhage from an experimental model in rabbits.
Gad Elkareem AM; de Smet MD
Acta Ophthalmol; 2014 Feb; 92(1):47-50. PubMed ID: 23025384
[TBL] [Abstract][Full Text] [Related]
9. Is thrombin a pharmacological target during reperfusion?
White HD
Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S55-7. PubMed ID: 10070820
[No Abstract] [Full Text] [Related]
10. Ocriplasmin for symptomatic vitreomacular adhesion.
Blue Cross and Blue Shield Association
Technol Eval Cent Assess Program Exec Summ; 2013 Aug; 28(5):1-3. PubMed ID: 24066370
[No Abstract] [Full Text] [Related]
11. [Pharmacological vitreolysis].
Gandorfer A
Klin Monbl Augenheilkd; 2011 Mar; 228(3):201-7. PubMed ID: 20845257
[TBL] [Abstract][Full Text] [Related]
12. [Fibrinolytic substances in thrombosis therapy].
Stamm H
Ther Ggw; 1972 Mar; 111(3):335-42. PubMed ID: 4260163
[No Abstract] [Full Text] [Related]
13. Leeches to hirulogs and other thrombin-directed antithrombotics.
Fenton JW
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1121-9. PubMed ID: 1400076
[TBL] [Abstract][Full Text] [Related]
14. [On fibrinolytic therapy of intravascular thrombosis (review of the literature)].
Gritsiuk AI
Ter Arkh; 1967 May; 39(5):12-9. PubMed ID: 4237762
[No Abstract] [Full Text] [Related]
15. [The treatment of acute arterial thrombosis and embolism of the extremities with thrombolytic preparations].
Drevina AI; Tokarev BV; Grinshtein EIa
Khirurgiia (Mosk); 1969 Jun; 45(6):26-30. PubMed ID: 4242052
[No Abstract] [Full Text] [Related]
16. [On several controversial questions on the use of fibrinolytic preparations in the treatment of thrombosis].
Mazur NA; Ruda MIa; Kats IA
Kardiologiia; 1967 Sep; 7(9):35-8. PubMed ID: 4238552
[No Abstract] [Full Text] [Related]
17. [The action of modified plasmin on the lysis of experimental thrombi].
Kizim AI; Pokrovskaia TN
Vrach Delo; 1990 May; (5):39-40. PubMed ID: 1697714
[No Abstract] [Full Text] [Related]
18. Experimental thrombolysis by perfusion. II. Comparative study on the effect of streptokinase, urokinase and plasmin.
Egeblad K; Bertelsen S
Acta Chir Scand; 1969; 135(6):486-90. PubMed ID: 4244115
[No Abstract] [Full Text] [Related]
19. [Long-lasting activation of the fibrinolytic system in blood and its clinical application].
Bielawiec M
Pol Tyg Lek; 1969 Jan; 24(2):63-6. PubMed ID: 4240415
[No Abstract] [Full Text] [Related]
20. [Thrombolytic therapy].
Matsuoka M
Saishin Igaku; 1968 Dec; 23(12):2612-20. PubMed ID: 4239635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
